Review Article

Overview of non-innovator biological products in India


Abstract: As per regulatory requirements, biosimilar drugs must show high similarity to their reference product in both pre-clinical and clinical tests. It is by these means that biosimilars are considered… Read More »

Page 5 of 5 « Previous1 2 3 4 5
Go Back Print